Seeking Alpha

Fears of a hepatitis C "serial infector" are rising after testing for more than 3,000 people who...

Fears of a hepatitis C "serial infector" are rising after testing for more than 3,000 people who may have been infected was cancelled by officials after the system became overwhelmed. A former lab technician at a New Hampshire hospital was indicted last week for allegedly infecting 31 people with the virus. Biotech shares that specialize in the field are active: GILD +0.5%, VRTX +1.3%, IDIX +1%.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs